Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Wirtitsch, MG; Findl, O; Heinzl, H; Drexler, W.
Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
Arch Ophthalmol. 2007; 125(10): 1345-1350.
Doi: 10.1001/archopht.125.10.1345
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Wirtitsch Matthias
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: To investigate the effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. DESIGN: Randomized, placebo-controlled, double-masked, 2-drug crossover study with 10 patients with cornea guttata and 10 healthy controls, who had mean endothelial cell counts of 988 and 2377 cells/mm(2), respectively. Study medications were 2% dorzolamide and placebo drops applied 3 times a day for 4 weeks. Central corneal thickness measurements using ACMaster (Carl Zeiss Meditec AG, Jena, Germany) and Goldmann applanation tonometry were performed at baseline, 1 day, 1 week, and 4 weeks. RESULTS: The mean increases in central corneal thickness after 4 weeks in eyes with cornea guttata treated with dorzolamide and placebo were 26.3 microm (95% confidence interval, 8.8 to 43.7) and 3.3 microm (95% confidence interval, -0.5 to 7.1), respectively. No statistically significant changes were measured in the healthy control group. Dorzolamide caused a significant decrease in intraocular pressure (P < .01) while placebo did not cause significant changes (P = .50). CONCLUSION: Application of dorzolamide for 4 weeks resulted in a statistically significant increase in central corneal thickness in patients with compromised corneal endothelium. These results indicate that patients with corneal endothelial problems receiving dorzolamide therapy should be monitored.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Body Weights and Measures -
- Carbonic Anhydrase Inhibitors - administration and dosage
- Cell Count - administration and dosage
- Cornea - drug effects
- Corneal Diseases - complications
- Corneal Edema - chemically induced
- Cross-Over Studies - chemically induced
- Double-Blind Method - chemically induced
- Endothelium, Corneal - pathology
- Female - pathology
- Humans - pathology
- Interferometry - pathology
- Intraocular Pressure - drug effects
- Light - drug effects
- Male - drug effects
- Middle Aged - drug effects
- Sulfonamides - administration and dosage
- Thiophenes - administration and dosage
- Tonometry, Ocular - administration and dosage